Jun 13, 2009 04:24PM
- comments
Tags: , , , , , , , , ,
I am at an interesting juncture here. I believe I am the first person to be prescribed Lacosomide (a recently FDA approved anti-convulsant) for tardive dyskinesia. The previous studies were tentative findings on rats. However, unlike the glycine which is still in Phase II FDA study, Lacosomide is FDA approved. However, this is the first day on it and my neurologist is a movement disorders specialist will have to do a final evaluation as well to determine if it works and how. The fact that it has a mitigating effect on tardive dystonia is concordant with the studies. The fact that I slept better and it worked on what was obviously rapid cycling would not be a surprise as many mood stabilizers (Lamictal, Keppra, Tegretol, Trileptal, etc.) were originally developed as anti convulsants. The fact that it has a mitigating effect on the dissociation/dysphoric mania of what they are tentatively terming tardive dysphrenia as well as the loss of cognition from what they are terming tardive dysmentia does point towards future recovery for others. They will have to evaluate me and understand it and then incorporate it in the case study to have a fuller understanding though and then that could be seen how it could apply to others. And the reason the picture is "blank" is because with the synapses starting to work together my reality testing is clear but in ways that had been disrupted neurologically previously. I have some understading of what is going on but its up to the researchers to fill in the blanks as to what happenned exactly. And then see how this picture could be used to help others fine tune things...
Post a Comment